Home

Uli Hacksell

CIK 1291962 · President and CEO · last filed 2020-04-02

Uli Hacksell is a President and CEO who has filed 45 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing, for CERC, was dated Apr 2, 2020. Across all open-market trades the lifetime net is −$11.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.4M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$4.36M

Companies

6

Total Filings

45

Lifetime Open-Market Net

-$10.99M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Avalo Therapeutics, Inc. (CERC) Delisted Director 20,000 $2.93 $58.6K $14.9K 7 2020-04-02
Avalo Therapeutics, Inc. (CERCW) Delisted Director — — — $0 1 2018-05-17
Avalo Therapeutics, Inc. (CERCZ) Delisted President and CEO — — — $0 1 2017-01-30
Avalo Therapeutics, Inc. (CERC.Z) Delisted President and CEO — — — $0 2 2016-08-19
Avalo Therapeutics, Inc. (CERC.U) Delisted Director — — — $0 1 2015-11-12
ACAD CEO 175,549 $24.84 $4.36M -$11.01M 32 2015-02-19

Recent Filings

45 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2020-04-02 Avalo Therapeutics, Inc. (CERC) Delisted Grant (A) — $0 EDGAR
2020-01-02 Avalo Therapeutics, Inc. (CERC) Delisted Grant (A) — $0 EDGAR
2019-10-03 Avalo Therapeutics, Inc. (CERC) Delisted Grant (A) — $0 EDGAR
2019-10-02 Avalo Therapeutics, Inc. (CERC) Delisted Grant (A) — $0 EDGAR
2019-07-02 Avalo Therapeutics, Inc. (CERC) Delisted Grant (A) — $0 EDGAR
2019-04-01 Avalo Therapeutics, Inc. (CERC) Delisted Mixed +20,000 $14.9K EDGAR
2019-01-02 Avalo Therapeutics, Inc. (CERC) Delisted Grant (A) — $0 EDGAR
2018-07-11 — Grant (A) — $0
2018-05-17 Avalo Therapeutics, Inc. (CERCW) Delisted Grant (A) — $0 EDGAR
2017-01-30 Avalo Therapeutics, Inc. (CERCZ) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 45
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.